Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

TMB-H × Other solid neoplasm × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Advanced Solid Tumors 149 Advanced Solid Tumor 136 Solid Tumor 110 Mesothelioma, Malignant 81 Mesothelioma 79 Solid Tumors 74 Hematopoietic and Lymphatic System Neoplasm 43 Solid Tumor, Adult 33 Carcinoma, Non-Small-Cell Lung 28 Ovarian Neoplasms 26 Retinoblastoma 25 Colorectal Neoplasms 21 Sarcoma 20 Pancreatic Neoplasms 20 Melanoma 20 Lung Neoplasms 20 Stomach Neoplasms 19 Carcinoma, Renal Cell 17 Neoplasms 16 Esophageal Neoplasms 16 Uterine Cervical Neoplasms 15 Malignant Solid Neoplasm 13 Hematopoietic and Lymphoid System Neoplasm 13 Triple Negative Breast Neoplasms 12 Neoplasm Metastasis 12 Cholangiocarcinoma 12 Advanced or Metastatic Solid Tumors 12 Advanced Malignant Solid Tumor 12 Advanced Malignant Solid Neoplasm 12 Urinary Bladder Neoplasms 11

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06365840 2025-06-18

TMB-H

ImmuneOncia Therapeutics Inc.

Phase 2 Recruiting

Other solid neoplasm

TMB-H

Data powered by HemOnc (CC BY 4.0) Colophon ⚡